SAN FRANCISCO--(BUSINESS WIRE)--Sept. 13, 2006--Evolved Nanomaterial Sciences (ENS), a Cambridge-based company that uses patented nanotechnology to revolutionize the chiral drug development process, announced today the release of ENS Chiral Solid Phase Extraction (SPE) cartridges that will allow chemists to enrich in minutes what currently takes hours using traditional methods. Initially, the Chiral SPE will be available in 1, 3, 6 mL cartridges and wellplates.
